Don Shaffer
Hematology & Oncology · Marietta, GANPI 1124023452
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (36.4%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. 37 manufacturers reported payments, led by Karyopharm Therapeutics Inc. at 32.4% of the total. Reporting peaked in 2021 at $2,271 and has fallen 96.4% since, to $81 in 2025. That places this record below the midpoint for hematology & oncology clinicians in GA, where the typical reported total is $4,479.
Across 116 payments — averaging $42.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Karyopharm Therapeutics Inc.$2K
- Rigel Pharmaceuticals, Inc.$1K
- AstraZeneca$204
- Seagen Inc.$202
- Pfizer$191
- Novartis$151
- plus $2K from 31 others
What the payments were for
- Consulting fees$1,65034%
- Speaking & faculty fees$1,15024%
- Food & beverage$1,77536%
- Education$3056%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Karyopharm Therapeutics Inc. | 3 | $1,581 |
| Rigel Pharmaceuticals, Inc. | 2 | $1,019 |
| AstraZeneca(2 entities) | 5 | $204 |
| Seagen Inc. | 10 | $202 |
| Pfizer | 14 | $191 |
| Novartis | 9 | $151 |
| Genentech USA, Inc. | 8 | $133 |
| Astellas Pharma US Inc | 3 | $112 |
| Amgen | 5 | $108 |
| AbbVie | 4 | $107 |
| Comsort, Inc | 1 | $100 |
| Bristol Myers Squibb | 5 | $77 |
| Merck | 4 | $69 |
| E.r. Squibb & Sons, L.L.C. | 4 | $66 |
| Exelixis Inc. | 3 | $65 |
| Incyte Corporation | 4 | $65 |
| Johnson & Johnson | 4 | $58 |
| Genentech, Inc. | 1 | $50 |
| Clovis Oncology, Inc. | 3 | $48 |
| Eisai Inc. | 2 | $48 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $43 |
| Blueprint Medicines Corporation | 2 | $40 |
| Array Biopharma Inc | 2 | $40 |
| Foundation Medicine, Inc. | 1 | $36 |
| Beigene USA, Inc. | 2 | $33 |
| Kyowa Kirin, Inc. | 2 | $28 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $25 |
| Daiichi Sankyo Inc. | 1 | $24 |
| Tersera Therapeutics LLC | 1 | $23 |
| GSK | 1 | $23 |
| Verastem, Inc. | 1 | $18 |
| Sanofi | 1 | $18 |
| Epizyme, Inc. | 1 | $17 |
| Lilly USA, LLC | 1 | $17 |
| Mylan Institutional Inc. | 1 | $15 |
| Regeneron Healthcare Solutions, Inc. | 1 | $13 |
| EMD Serono, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,880 in reported general payments places this provider in the 50th percentile of 370 hematology & oncology providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gamunex-CImmune Globul G/Gly/Iga Avg 46 | 15 | $62,466 |
Paid to pharmacies, not to this prescriber.
Other hematology & oncology in Marietta
- Steven McCuneMarietta$450K
- Gena Volas ReddMarietta$77K
- John FrenchMarietta$70K
- Dean KirkelMarietta$44K
- Priya RudolphAthens$745K
- Aron KefelaHiram$591K
- Chandar BhimaniConyers$483K
- Ticiana LealAtlanta$450K
- Jorge LeguizamoLawrenceville$409K
- Trevor FeinsteinFayetteville$341K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.